Market Overview The global multiple sclerosis market was valued at USD 25.0 billion in 2024 and is expected to grow at a CAGR of 5.0 % from 2025 to 2034. Growth is driven by increased healthcare expenditure and ongoing developments in disease-modifying therapies. Geriatric medicines refer to pharmaceuticals and therapeutic formulations specifically designed for older adults (aged 65 and above),...